The announcement follows the publication Friday by the Lancet medical journal of an observational study on hydroxychloroquine and chloroquine and its effects on hospitalized Covid-19 patients. “The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board,” said WHO Director-General Tedros Adhanom Ghebreyesus. On April 19, US President Donald Trump said he had been taking hydroxychloroquine, which he has repeatedly touted for the treatment of coronavirus patients. I’m taking it, hydroxychloroquine. The Executive Group of the WHO’s Solidarity Trial, representing 10 of the participating countries, met Saturday and agreed to review a comprehensive analysis and critical appraisal of all evidence available globally.

Source: The Express Tribune May 26, 2020 06:11 UTC